Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

4B.08: SERUM LEVELS OF TIMP-1 AND IL-6 ARE ASSOCIATED WITH HYPERTENSION AND ATHEROSCLEROSIS IN PATIENTS WITH EARLY STAGES OF CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETIC NEPHROPATHY.

Dimas G, Iliadis F, Tegos T, Spiroglou S, Kanellos I, Karamouzis I, Savopoulos C, Hatzitolios A, Grekas D.

J Hypertens. 2015 Jun;33 Suppl 1:e55. doi: 10.1097/01.hjh.0000467492.91729.d5.

PMID:
26102854
2.

4A.05: CIRCULATING FGF-23 AS AN INDEPENDENT CORRELATE OF HYPERTENSION AND ATHEROSCLEROSIS IN EARLY STAGES OF CKD.

Dimas G, Iliadis F, Tegos T, Spiroglou S, Kanellos I, Karamouzis I, Savopoulos C, Hatzitolios A, Grekas D.

J Hypertens. 2015 Jun;33 Suppl 1:e50. doi: 10.1097/01.hjh.0000467479.89943.a3.

PMID:
26102841
3.

Riedel's lobe of the liver: a case report.

Savopoulos C, Kakaletsis N, Kaiafa G, Iliadis F, Kalogera-Fountzila A, Hatzitolios AI.

Medicine (Baltimore). 2015 Jan;94(3):e430. doi: 10.1097/MD.0000000000000430.

4.

TNF-α and microalbuminuria in patients with type 2 diabetes mellitus.

Lampropoulou IT, Stangou M, Papagianni A, Didangelos T, Iliadis F, Efstratiadis G.

J Diabetes Res. 2014;2014:394206. doi: 10.1155/2014/394206.

5.

Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus.

Zografou I, Sampanis C, Gkaliagkousi E, Iliadis F, Papageorgiou A, Doukelis P, Vogiatzis K, Douma S.

Hormones (Athens). 2015 Jan-Mar;14(1):118-25. doi: 10.14310/horm.2002.1512.

6.
7.

Initially lymphocytic Sweet's syndrome in male patients with myelodysplasia: a distinguished clinicopathological entity? Case report and systematic review of the literature.

Kakaletsis N, Kaiafa G, Savopoulos C, Iliadis F, Perifanis V, Tzalokostas V, Grekou A, Giannouli A, Hatzitolios AI.

Acta Haematol. 2014;132(2):220-5. Review.

PMID:
24714374
8.

Left ventricular systolic and diastolic function in normotensive type 2 diabetic patients with or without autonomic neuropathy: a radionuclide ventriculography study.

Didangelos TP, Arsos G, Karamitsos T, Iliadis F, Papageorgiou A, Moralidis E, Athyros V.

Angiology. 2014 Nov;65(10):877-82. doi: 10.1177/0003319713510966.

PMID:
24265250
9.

The prognostic efficacy of myocardial perfusion imaging in optimally treated diabetic patients with no manifestations of coronary artery disease.

Kakaletsis N, Moralidis E, Iliadis F, Hilidis I, Gotzamani-Psarrakou A, Didangelos T.

Nucl Med Commun. 2013 Sep;34(9):885-92. doi: 10.1097/MNM.0b013e328362cc81.

PMID:
23719151
10.

Impaired fasting glucose in hypertensive patients: prevalence and cross-sectional analysis of associations with cardiovascular disease.

Tziomalos K, Spanou M, Baltatzi M, Efthymiou E, Psianou K, Papastergiou N, Iliadis F, Didangelos TP, Savopoulos C, Hatzitolios AI.

Diabetes Technol Ther. 2013 Jun;15(6):475-80. doi: 10.1089/dia.2012.0336.

PMID:
23544673
11.

Network-centric Analysis of Genetic Predisposition in Diabetic Nephropathy.

Ntemka A, Iliadis F, Papanikolaou N, Grekas D.

Hippokratia. 2011 Jul;15(3):232-7.

12.

Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.

Baltazi M, Katsiki N, Savopoulos C, Iliadis F, Koliakos G, Hatzitolios AI.

Am J Cardiovasc Dis. 2011;1(1):48-59.

13.

Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations?

Iliadis F, Didangelos T, Ntemka A, Makedou A, Moralidis E, Gotzamani-Psarakou A, Kouloukourgiotou T, Grekas D.

Diabetologia. 2011 Dec;54(12):2987-94. doi: 10.1007/s00125-011-2307-1.

PMID:
21947381
14.

Insulin and the heart.

Iliadis F, Kadoglou N, Didangelos T.

Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S86-91. doi: 10.1016/S0168-8227(11)70019-5. Review.

PMID:
21864757
15.

Insulin therapy during hospitalization.

Zantidis A, Iliadis F, Didangelos T.

Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S78-85. doi: 10.1016/S0168-8227(11)70018-3. Review.

PMID:
21864756
16.

Insulin pump therapy in adults.

Didangelos T, Iliadis F.

Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S109-13. doi: 10.1016/S0168-8227(11)70025-0. Review.

PMID:
21864741
17.

Exercise training ameliorates the effects of rosiglitazone on traditional and novel cardiovascular risk factors in patients with type 2 diabetes mellitus.

Kadoglou NP, Iliadis F, Sailer N, Athanasiadou Z, Vitta I, Kapelouzou A, Karayannacos PE, Liapis CD, Alevizos M, Angelopoulou N, Vrabas IS.

Metabolism. 2010 Apr;59(4):599-607. doi: 10.1016/j.metabol.2009.09.002.

PMID:
19922961
18.

Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study.

Athyros VG, Hatzitolios A, Karagiannis A, Didangelos TP, Iliadis F, Dolgyras S, Vosnakidis T, Vasiliadis P, Malias I, Tziomalos K, Samouilidou M, Mikhailidis DP; INDEED Collaborative Group..

Curr Med Res Opin. 2009 Aug;25(8):1931-40. doi: 10.1185/03007990903073035.

PMID:
19558210
19.

Is the anti-hypertensive effect of dietary supplements via aldehydes reduction evidence based? A systematic review.

Hatzitolios A, Iliadis F, Katsiki N, Baltatzi M.

Clin Exp Hypertens. 2008 Oct;30(7):628-39. doi: 10.1080/10641960802443274. Review.

PMID:
18855266
20.

Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.

Baltatzi M, Hatzitolios A, Tziomalos K, Iliadis F, Zamboulis Ch.

Int J Clin Pract. 2008 Sep;62(9):1432-40. doi: 10.1111/j.1742-1241.2008.01823.x. Review.

PMID:
18793378
Items per page

Supplemental Content

Loading ...
Support Center